Active Pharmaceutical Ingredients

• Treatment of open-angle glaucoma
• Management of ocular hypertension
• Prevention of intraocular pressure elevation following anterior segment laser surgery

• Selective α2-adrenergic agonist
• Reduces intraocular pressure (IOP) by decreasing aqueous humor production and increasing uveoscleral outflow
• Potential neuroprotective effects

• Hypersensitivity to brimonidine or any component of the formulation
• Patients undergoing treatment with monoamine oxidase inhibitors

• Dry mouth, fatigue, eye irritation (burning, stinging)
• Headache, blurred vision, eye discomfort
• Conjunctival filtration, allergic reactions

(Note: The incidence of side effects may vary among individuals)

• Use cautiously in patients with severe cardiovascular disease
• Monitor IOP regularly in patients using IOP-lowering medications
• Wait at least 15 minutes after instillation before inserting soft contact lenses